JPS61204198A - ２−オキサプレグナン化合物 - Google Patents

２−オキサプレグナン化合物

Info

Publication number
JPS61204198A
JPS61204198A JP60043731A JP4373185A JPS61204198A JP S61204198 A JPS61204198 A JP S61204198A JP 60043731 A JP60043731 A JP 60043731A JP 4373185 A JP4373185 A JP 4373185A JP S61204198 A JPS61204198 A JP S61204198A
Authority
JP
Japan
Prior art keywords
compound
formula
dione
acetoxy
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60043731A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0149358B2 (enrdf_load_stackoverflow
Inventor
Takeo Shibata
柴田　健雄
Nobuaki Yamagoshi
山腰　信明
Naoyuki Koizumi
直之 小泉
Yoshihiro Takegawa
恵弘 竹川
Eiichiro Shimazawa
島澤　英一郎
Mamoru Saegusa
三枝　衛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Teikoku Hormone Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Hormone Manufacturing Co Ltd filed Critical Teikoku Hormone Manufacturing Co Ltd
Priority to JP60043731A priority Critical patent/JPS61204198A/ja
Priority to EP86102537A priority patent/EP0193871B1/en
Priority to DE8686102537T priority patent/DE3663668D1/de
Priority to US06/833,715 priority patent/US4785103A/en
Priority to AT86102537T priority patent/ATE43608T1/de
Priority to NZ215328A priority patent/NZ215328A/xx
Priority to AU54245/86A priority patent/AU576945B2/en
Priority to CA000503465A priority patent/CA1255293A/en
Priority to ES552724A priority patent/ES8801669A1/es
Priority to IN156/MAS/86A priority patent/IN162700B/en
Priority to KR1019860001625A priority patent/KR900006219B1/ko
Publication of JPS61204198A publication Critical patent/JPS61204198A/ja
Priority to ES557573A priority patent/ES8801928A1/es
Priority to ES557572A priority patent/ES8801670A1/es
Priority to ES557574A priority patent/ES8801510A1/es
Priority to IN800/MAS/87A priority patent/IN166059B/en
Priority to US07/228,316 priority patent/US4914106A/en
Publication of JPH0149358B2 publication Critical patent/JPH0149358B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP60043731A 1985-03-07 1985-03-07 ２−オキサプレグナン化合物 Granted JPS61204198A (ja)

Priority Applications (16)

Application Number Priority Date Filing Date Title
JP60043731A JPS61204198A (ja) 1985-03-07 1985-03-07 ２−オキサプレグナン化合物
EP86102537A EP0193871B1 (en) 1985-03-07 1986-02-27 2-oxa- or aza-pregnane compounds
DE8686102537T DE3663668D1 (de) 1985-03-07 1986-02-27 2-oxa- or aza-pregnane compounds
US06/833,715 US4785103A (en) 1985-03-07 1986-02-27 2-oxa- or -aza-pregnane compounds
AT86102537T ATE43608T1 (de) 1985-03-07 1986-02-27 2-oxa- oder -aza-pregnanderivate.
NZ215328A NZ215328A (en) 1985-03-07 1986-02-28 2-oxa or aza pregnanes and pharmaceutical compositions
AU54245/86A AU576945B2 (en) 1985-03-07 1986-03-04 2-oxa-or-aza-pregnane compounds and there use in controlling androgenic dependant diseases
CA000503465A CA1255293A (en) 1985-03-07 1986-03-06 2-oxa- or -aza-pregnane compounds
ES552724A ES8801669A1 (es) 1985-03-07 1986-03-06 Un procedimiento para preparar nuevos compuestos de 2-oxa-0 aza-pregnano.
IN156/MAS/86A IN162700B (enrdf_load_stackoverflow) 1985-03-07 1986-03-07
KR1019860001625A KR900006219B1 (ko) 1985-03-07 1986-03-07 2-옥사-또는-아자-프레그난 화합물의 제조방법
ES557573A ES8801928A1 (es) 1985-03-07 1987-05-29 Un procedimiento para preparar nuevos compuestos de 2-oxa pregnano.
ES557572A ES8801670A1 (es) 1985-03-07 1987-05-29 Un procedimiento para preparar nuevos compuestos de 2-oxa pregnano.
ES557574A ES8801510A1 (es) 1985-03-07 1987-05-29 Un procedimiento para preparar nuevos compuestos de 2-oxa-o -aza-pregnano
IN800/MAS/87A IN166059B (enrdf_load_stackoverflow) 1985-03-07 1987-11-06
US07/228,316 US4914106A (en) 1985-03-07 1988-08-04 Compositions and methods employing 2-oxa- or -aza-pregnan compounds for inhibiting androgen or supplying progestin in mammals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60043731A JPS61204198A (ja) 1985-03-07 1985-03-07 ２−オキサプレグナン化合物

Publications (2)

Publication Number Publication Date
JPS61204198A true JPS61204198A (ja) 1986-09-10
JPH0149358B2 JPH0149358B2 (enrdf_load_stackoverflow) 1989-10-24

Family

ID=12671923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60043731A Granted JPS61204198A (ja) 1985-03-07 1985-03-07 ２−オキサプレグナン化合物

Country Status (2)

Country Link
JP (1) JPS61204198A (enrdf_load_stackoverflow)
KR (1) KR900006219B1 (enrdf_load_stackoverflow)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017195804A1 (ja) * 2016-05-11 2017-11-16 あすか製薬株式会社 １５β－ヒドロキシ－酢酸オサテロンの結晶多形
WO2021065027A1 (ja) 2019-10-02 2021-04-08 あすか製薬株式会社 排尿障害改善剤
KR20220079570A (ko) 2019-10-02 2022-06-13 아스카 세이야쿠 가부시키가이샤 배뇨 장애 개선제
WO2022131354A1 (ja) 2020-12-18 2022-06-23 あすか製薬株式会社 固形製剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5421329A (en) * 1977-07-18 1979-02-17 Hitachi Ltd Control system for cameras

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5421329A (en) * 1977-07-18 1979-02-17 Hitachi Ltd Control system for cameras

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017195804A1 (ja) * 2016-05-11 2017-11-16 あすか製薬株式会社 １５β－ヒドロキシ－酢酸オサテロンの結晶多形
JPWO2017195804A1 (ja) * 2016-05-11 2019-03-07 あすか製薬株式会社 １５β−ヒドロキシ−酢酸オサテロンの結晶多形
US10508130B2 (en) 2016-05-11 2019-12-17 Aska Pharmaceutical Co., Ltd. Crystalline polymorph of 15B-hydroxy-osaterone acetate
EA034965B1 (ru) * 2016-05-11 2020-04-13 Аска Фармасьютикал Ко., Лтд. Кристаллический полиморф 15бета-гидроксиосатерона ацетата
WO2021065027A1 (ja) 2019-10-02 2021-04-08 あすか製薬株式会社 排尿障害改善剤
KR20220079570A (ko) 2019-10-02 2022-06-13 아스카 세이야쿠 가부시키가이샤 배뇨 장애 개선제
WO2022131354A1 (ja) 2020-12-18 2022-06-23 あすか製薬株式会社 固形製剤

Also Published As

Publication number Publication date
KR860007241A (ko) 1986-10-10
KR900006219B1 (ko) 1990-08-25
JPH0149358B2 (enrdf_load_stackoverflow) 1989-10-24

Similar Documents

Publication Publication Date Title
JPS6089474A (ja) モルフイナン誘導体，その製造方法，及び該化合物を含有する抗腫瘍剤
JPS6383095A (ja) ４−置換６−アルキリデンアンドロステン−３，１７−ジオン誘導体およびその製造方法
JP3913475B2 (ja) ステロイドスルファターゼ阻害剤並びに該阻害剤の製造及び使用方法
AU3159293A (en) New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
WO1997026242A1 (fr) Derives de 3-(bis-phenylmethylene substitue) oxindole
JPS61204198A (ja) ２−オキサプレグナン化合物
EP0193871B1 (en) 2-oxa- or aza-pregnane compounds
US4183924A (en) 17α-Chloro-17β-hydrocarbonsulfinyl-1,4-androstadienes and the corresponding 17β-hydrocarbonsulfonyl derivatives and their use as anti-acne agents
DE4330237C2 (de) 1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0099091B1 (en) Hexahydrodioxopyrimidines, their production and use
CA2142560C (fr) Nouveaux analogues de l'acronycine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPS63101397A (ja) １，２β−メチレン−４−置換アンドロステン−３，１７−ジオン誘導体およびその製造方法
EP0278732B1 (en) Fluorine-containing vitamin d2 derivatives
JP2627441B2 (ja) １―アセトキシム―２―ニトロイミダゾール誘導体
JPS62195398A (ja) 黄体ホルモン剤
JPH0123478B2 (enrdf_load_stackoverflow)
CA2139549A1 (en) Corticoid derivatives and pharmaceutical and cosmetic compositions
IE43311B1 (en) 1-methyl-2-(pyridyloxmyethyl)-5-nitroimidazoles and process for preparing them
WO1992020646A1 (fr) Nouveaux sels d'ammonium quaternaire, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2600254A1 (fr) Derives methylenes des androstene-4 diones-3, 17, leur procede de preparation, et leur application comme medicaments
EP0147174A2 (en) Dihydroxybenzaldehyde derivatives as anti-inflammatory agents
JPH07252294A (ja) 副腎皮質ステロイド誘導体
JPH08157475A (ja) １−ヒドロキシインドール誘導体
JPH01197486A (ja) 新規ポドフィロトキシン誘導体、抗腫瘍剤及び中間体
JPH064582B2 (ja) ベンゾキノニルフエニル酪酸アミド誘導体

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees